Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Five things to know about...metformin and intravenous contrast.

Literature DB >> 23048079

Five things to know about...metformin and intravenous contrast.

Mark Otto Baerlocher¹, Murray Asch, Andy Myers.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2012 PMID： 23048079 PMCID： PMC3537815 DOI： 10.1503/cmaj.090550

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

5 in total

1. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee.

Authors: H S Thomsen; S K Morcos
Journal: Eur Radiol Date: 1999 Impact factor: 5.315

Review 2. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.

Authors: Stacy K Goergen; Gregory Rumbold; Gregory Compton; Claire Harris
Journal: Radiology Date: 2010-01 Impact factor: 11.105

3. Lactic acidosis in patients with diabetes treated with metformin.

Authors: R I Misbin; L Green; B V Stadel; J L Gueriguian; A Gubbi; G A Fleming
Journal: N Engl J Med Date: 1998-01-22 Impact factor: 91.245

Review 4. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors: Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal: Eur Radiol Date: 2011-08-25 Impact factor: 5.315

5. Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions.

Authors: Veysel Oktay; İlknur Calpar Çıralı; Ümit Yaşar Sinan; Ahmet Yıldız; Murat Kazım Ersanlı
Journal: Anatol J Cardiol Date: 2017-10-31 Impact factor: 1.596

5 in total

Five things to know about...metformin and intravenous contrast.

1. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee.

Review 2. Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.

3. Lactic acidosis in patients with diabetes treated with metformin.

Review 4. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

5. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy.

Review 1. Updated guidelines for intravenous contrast use for CT and MRI.

Review 2. A Comprehensive Review of Drug-Drug Interactions with Metformin.

Review 3. Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes.

4. A stewardship intervention program for safe medication management and use of antidiabetic drugs.

5. Impact of continuation of metformin prior to elective coronary angiography on acute contrast nephropathy in patients with normal or mildly impaired renal functions.